These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 23196935

  • 1. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania.
    Hawkins C, Christian B, Ye J, Nagu T, Aris E, Chalamilla G, Spiegelman D, Mugusi F, Mehta S, Fawzi W.
    AIDS; 2013 Mar 27; 27(6):919-927. PubMed ID: 23196935
    [Abstract] [Full Text] [Related]

  • 2. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S, Fairley CK, Sasadeusz J, He J, Wei X, Zeng H, Jing J, Mao L, Chen X, Zhang L.
    J Med Virol; 2018 Mar 27; 90(3):518-525. PubMed ID: 29091279
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy.
    Christian B, Fabian E, Macha I, Mpangala S, Thio CL, Ulenga N, Mugusi F, Ammerman LR, Fawzi W, Green R, Murphy R, Hawkins C.
    AIDS; 2019 Mar 01; 33(3):465-473. PubMed ID: 30702515
    [Abstract] [Full Text] [Related]

  • 4. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL.
    Clin Infect Dis; 2009 Oct 15; 49(8):1268-73. PubMed ID: 19772386
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA.
    J Med Virol; 2012 Jan 15; 84(1):6-10. PubMed ID: 22095533
    [Abstract] [Full Text] [Related]

  • 6. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.
    Yang R, Gui X, Xiong Y, Gao SC, Yan Y.
    Int J Infect Dis; 2014 Nov 15; 28():29-34. PubMed ID: 25236390
    [Abstract] [Full Text] [Related]

  • 7. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R, Mutocheluh M, Dompreh A, Obiri-Yeboah D, Odame Anto E, Owusu M, Narkwa PW.
    PLoS One; 2019 Nov 15; 14(4):e0215377. PubMed ID: 31002687
    [Abstract] [Full Text] [Related]

  • 8. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L, Moh R, Abdou Chekaraou M, Gabillard D, Anglaret X, Eholié SP, Zoulim F, Danel C, Lacombe K, Boyd A.
    AIDS Res Hum Retroviruses; 2018 May 15; 34(5):439-445. PubMed ID: 29466862
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM.
    PLoS One; 2016 May 15; 11(3):e0150512. PubMed ID: 26933963
    [Abstract] [Full Text] [Related]

  • 10. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM, Boyd A, Moh R, Badje A, Gabillard D, Ouattara E, Ntakpe JB, Emième A, Maylin S, Chekaraou MA, Eholié SP, Zoulim F, Lacombe K, Anglaret X, Danel C, French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups.
    Clin Infect Dis; 2018 Jan 06; 66(1):112-120. PubMed ID: 29020361
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
    van Griensven J, Phirum L, Choun K, Thai S, De Weggheleire A, Lynen L.
    PLoS One; 2014 Jan 06; 9(2):e88552. PubMed ID: 24533106
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
    Wandeler G, Musukuma K, Zürcher S, Vinikoor MJ, Llenas-García J, Aly MM, Mulenga L, Chi BH, Ehmer J, Hobbins MA, Bolton-Moore C, Hoffmann CJ, Egger M, IeDEA-Southern Africa.
    PLoS One; 2016 Jan 06; 11(3):e0152043. PubMed ID: 27032097
    [Abstract] [Full Text] [Related]

  • 13. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
    Boyd A, Houghtaling L, Moh R, Chekaraou MA, Gabillard D, Eholié SP, Anglaret X, Zoulim F, Danel C, Lacombe K, For The Anrs Trivacan And Anrs VarBVA Studies.
    Am J Trop Med Hyg; 2017 Dec 06; 97(6):1936-1942. PubMed ID: 29141712
    [Abstract] [Full Text] [Related]

  • 14. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
    Archampong TN, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Gillani FS, Yang H, Boamah I, Flanigan T, Kwara A.
    BMC Infect Dis; 2016 Jan 13; 16():14. PubMed ID: 26759172
    [Abstract] [Full Text] [Related]

  • 15. Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy.
    Day SL, Odem-Davis K, Mandaliya KN, Jerome KR, Cook L, Masese LN, Scott J, Kim HN, Graham SM, McClelland RS.
    PLoS One; 2013 Jan 13; 8(3):e59346. PubMed ID: 23527168
    [Abstract] [Full Text] [Related]

  • 16. High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
    Jia HH, Li KW, Chen QY, Wang XY, Harrison TJ, Liang SJ, Yang QL, Wang C, Hu LP, Ren CC, Fang ZL.
    Intervirology; 2018 Jan 13; 61(3):123-132. PubMed ID: 30368502
    [Abstract] [Full Text] [Related]

  • 17. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
    Huang SM, Cai WP, Hu FY, Lan Y, Liao BL, Chen YP, Tang XP.
    Int J STD AIDS; 2016 Sep 13; 27(10):890-7. PubMed ID: 26384940
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
    Chadwick D, Ankcorn M, Sarfo F, Phillips R, Fox Z, Garcia A, Appiah L, Bedu-Addo G, Geretti AM.
    J Antimicrob Chemother; 2012 Dec 13; 67(12):2939-42. PubMed ID: 22915461
    [Abstract] [Full Text] [Related]

  • 19. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, Sigaloff KC, Hoepelman AI, Stevens WS, Rinke de Wit TF, PharmAccess African Studies to Evaluate Resistance (PASER).
    J Acquir Immune Defic Syndr; 2013 Oct 01; 64(2):174-82. PubMed ID: 23892239
    [Abstract] [Full Text] [Related]

  • 20. Influence of hepatitis B virus co-infection on virological and immunological response to antiretroviral treatment among HIV patients attending comprehensive care clinics in Makueni County, Kenya.
    Maitha GM, Kikuvi G, Wanzala P, Kirui F.
    Pan Afr Med J; 2021 Oct 01; 38():103. PubMed ID: 33889269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.